Molecular basis of primary hyperoxaluria: clues to innovative treatments
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular basis of primary hyperoxaluria: clues to innovative treatments
Authors
Keywords
-
Journal
Urolithiasis
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-14
DOI
10.1007/s00240-018-1089-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxalate-Degrading Enzyme Recombined Lactic Acid Bacteria Strains Reduce Hyperoxaluria
- (2018) Chenming Zhao et al. UROLOGY
- Opposite effect of polymorphic mutations on the electrostatic aggregation of human alanine:glyoxylate aminotransferase: implications for the pathogenesis of Primary Hyperoxaluria Type I
- (2017) Mirco Dindo et al. FEBS Journal
- Coutinho et al. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders. Int. J. Mol. Sci. 2016, 17, 1065
- (2017) Maria Coutinho et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Correlation between the molecular effects of mutations at the dimer interface of alanine–glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6
- (2017) Mirco Dindo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I
- (2017) Alessandro Roncador et al. Nanomedicine-Nanotechnology Biology and Medicine
- A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
- (2017) Dawn Milliner et al. Urolithiasis
- Treatment options in primary hyperoxaluria Type I
- (2017) Barbara Cellini Expert Opinion on Orphan Drugs
- Protein Quality Control by Molecular Chaperones in Neurodegeneration
- (2017) Aaron Ciechanover et al. Frontiers in Neuroscience
- A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme
- (2016) Craig B. Langman et al. AMERICAN JOURNAL OF NEPHROLOGY
- Metabolism of 13C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase
- (2016) Xingsheng Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T
- (2016) Mirco Dindo et al. BIOCHIMIE
- Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I
- (2016) Elisa Oppici et al. CURRENT DRUG TARGETS
- HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients
- (2016) Saoussen M'dimegh et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Oxalobacter formigenes–Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells
- (2016) Donna Arvans et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
- (2016) Abigail Liebow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
- (2016) Chaitali Dutta et al. MOLECULAR THERAPY
- Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I
- (2016) Cristina Martin-Higueras et al. MOLECULAR THERAPY
- Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients
- (2016) Bouwien E. Smid et al. Orphanet Journal of Rare Diseases
- siRNA and RNAi optimization
- (2016) Adele Alagia et al. Wiley Interdisciplinary Reviews-RNA
- The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man
- (2016) Jonathan M. Whittamore et al. Urolithiasis
- The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I
- (2015) Elisa Oppici et al. ACS Chemical Biology
- Direct and Functional Biomarkers of Vitamin B6 Status
- (2015) Per Magne Ueland et al. Annual Review of Nutrition
- Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening
- (2015) Franck Madoux et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine
- (2015) Riccardo Montioli et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview
- (2015) Elisa Oppici et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1
- (2015) R Castello et al. GENE THERAPY
- Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I
- (2015) Elisa Oppici et al. HUMAN MOLECULAR GENETICS
- Enteric hyperoxaluria: an important cause of end-stage kidney disease
- (2015) Lama Nazzal et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Surgical Management of Stone Disease in Patients With Primary Hyperoxaluria
- (2015) Alonso Carrasco et al. UROLOGY
- Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
- (2015) Ammon B. Peck et al. Urolithiasis
- The consensus-based approach for gene/enzyme replacement therapies and crystallization strategies: the case of human alanine–glyoxylate aminotransferase
- (2014) Noel Mesa-Torres et al. BIOCHEMICAL JOURNAL
- The lower limits for protein stability and foldability in primary hyperoxaluria type I
- (2014) Noel Mesa-Torres et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- A mutation creating an out-of-frame alternative translation initiation site in theGRHPR5′UTR causing primary hyperoxaluria type II
- (2014) Y. Fu et al. CLINICAL GENETICS
- Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice
- (2014) H. Hoyer-Kuhn et al. Clinical Journal of the American Society of Nephrology
- Primary hyperoxalurias: diagnosis and treatment
- (2014) Efrat Ben-Shalom et al. PEDIATRIC NEPHROLOGY
- The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I
- (2014) Noel Mesa-Torres et al. PLoS One
- Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1
- (2014) Non Miyata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteostasis impairment in protein-misfolding and -aggregation diseases
- (2014) Mark S. Hipp et al. TRENDS IN CELL BIOLOGY
- Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts
- (2014) Georgios Karaolanis et al. Transplantation Reviews
- Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria
- (2014) Klara Klimesova et al. Urolithiasis
- Ethnic differences inGRHPRmutations in patients with primary hyperoxaluria type 2
- (2013) T. Takayama et al. CLINICAL GENETICS
- Primary Hyperoxaluria
- (2013) Pierre Cochat et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary hyperoxaluria type 1: practical and ethical issues
- (2013) Pierre Cochat et al. PEDIATRIC NEPHROLOGY
- Protein Homeostasis Defects of Alanine-Glyoxylate Aminotransferase: New Therapeutic Strategies in Primary Hyperoxaluria Type I
- (2013) Angel L. Pey et al. Biomed Research International
- A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion
- (2013) Marguerite Hatch et al. Urolithiasis
- 4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition
- (2012) Travis J. Riedel et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Primary hyperoxalurias: Disorders of glyoxylate detoxification
- (2012) Eduardo Salido et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies
- (2012) Bodo B Beck et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions
- (2012) Bodo B Beck et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Enzyme replacement therapy for Fabry disease: a systematic review and meta-analysis
- (2012) Taciane Alegra et al. GENETICS AND MOLECULAR BIOLOGY
- TAT-Mediated Delivery of Human Alanine:Glyoxylate Aminotransferase in a Cellular Model of Primary Hyperoxaluria Type I
- (2012) Alessandro Roncador et al. International Journal of Peptide Research and Therapeutics
- Second Place: The Effects of Oxazyme on Oxalate Degradation: Results and Implications of In Vitro Experiments
- (2012) Patrick W. Mufarrij et al. JOURNAL OF ENDOUROLOGY
- Primary hyperoxaluria type III—a model for studying perturbations in glyoxylate metabolism
- (2012) Ruth Belostotsky et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- An update on primary hyperoxaluria
- (2012) Bernd Hoppe Nature Reviews Nephrology
- Liver cell transplantation in severe infantile oxalosis--a potential bridging procedure to orthotopic liver transplantation?
- (2012) B. B. Beck et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
- (2012) P. Cochat et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Reduction of Plasma Oxalate Levels by Oral Application of Oxalobacter formigenes in 2 Patients With Infantile Oxalosis
- (2011) Bernd Hoppe et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Primary Hyperoxaluria Type III Gene HOGA1 (Formerly DHDPSL) as a Possible Risk Factor for Idiopathic Calcium Oxalate Urolithiasis
- (2011) C. G. Monico et al. Clinical Journal of the American Society of Nephrology
- Molecular insights into primary hyperoxaluria Type I pathogenesis
- (2011) Barbara Cellini Frontiers in Bioscience-Landmark
- Exploring glycolate oxidase (GOX) as an antiurolithic drug target: Molecular modeling and in vitro inhibitor study
- (2011) A.L. Shirfule et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Hyperoxaluria: a gut–kidney axis?
- (2011) Stef Robijn et al. KIDNEY INTERNATIONAL
- Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
- (2011) B. Hoppe et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter
- (2010) Marguerite Hatch et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria
- (2010) Angel L. Pey et al. AMINO ACIDS
- Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants
- (2010) Barbara Cellini et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Primary hyperoxaluria type 1: strategy for organ transplantation
- (2010) Pierre Cochat et al. Current Opinion in Organ Transplantation
- Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation
- (2010) John C. Lieske et al. KIDNEY INTERNATIONAL
- Phenotypic Correction of a Mouse Model for Primary Hyperoxaluria With Adeno-associated Virus Gene Transfer
- (2010) Eduardo Salido et al. MOLECULAR THERAPY
- Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I
- (2010) B. Cellini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of human glycolate oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1,2,3-thiadiazole
- (2009) Jean-Marie Bourhis et al. Acta Crystallographica Section F-Structural Biology and Crystallization Communications
- Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
- (2009) Evan T. Powers et al. Annual Review of Biochemistry
- Primary hyperoxaluria type 1: update and additional mutation analysis of theAGXTgene
- (2009) Emma L. Williams et al. HUMAN MUTATION
- Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation
- (2009) Barbara Cellini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
- (2009) Jérôme Harambat et al. KIDNEY INTERNATIONAL
- Pxmp2 Is a Channel-Forming Protein in Mammalian Peroxisomal Membrane
- (2009) Aare Rokka et al. PLoS One
- Hyperoxaluria Is Reduced and Nephrocalcinosis Prevented with an Oxalate-Degrading Enzyme in Mice with Hyperoxaluria
- (2008) Danica Grujic et al. AMERICAN JOURNAL OF NEPHROLOGY
- Active Site and Loop 4 Movements within Human Glycolate Oxidase: Implications for Substrate Specificity and Drug Design†
- (2008) Michael S. Murray et al. BIOCHEMISTRY
- Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants
- (2008) M.B. Coulter-Mackie et al. MOLECULAR GENETICS AND METABOLISM
- The Roles and Mechanisms of Intestinal Oxalate Transport in Oxalate Homeostasis
- (2008) Marguerite Hatch et al. SEMINARS IN NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now